Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
HANGZHOU, China and SHANGHAI and BOSTON, July 15, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that...
Cappfinity Announces Launch of New Leadership Contribution Platform
LONDON, July 14, 2026 /PRNewswire/ -- Cappfinity today announces the launch of its new Leadership Contribution Platform, a comprehensive assessment and development solution designed to redefine how organisations understand, measure, and accelerate...
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI
ABU DHABI, UAE, July 14, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) ("Robo.ai" or the "Company") today announced a series of senior executive appointments in its subsidiary Neurovia AI, an AI visual data processing and compression technology...
Elong Power Holding Limited Announces Closing of US$6.6 Million Public Offering
BEIJING, July 14, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D, sales and scenario-oriented system solutions of lithium-ion battery energy storage...
Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China
SHANGHAI, July 13, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced that the first participant has been dosed in its Phase 1 clinical trial of DX-104...
Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European...
OlloBot Reveals OlloNi SS1's New Identity Design and Announces Ollo-Family Blind Box Launch at Houston Pop-Up This July
NEW YORK, July 10, 2026 /PRNewswire/ -- OlloBot unveiled the core upgrades of the OlloNi SS1, marking a comprehensive leap forward in design and AI capabilit for its highly anticipated family companion cyber-pet robot. At the same time, OlloBot has...
e& Announces USD 5.95 Billion Sale of Vodafone Investment
ABU DHABI, UAE, July 10, 2026 /PRNewswire/ -- Following a comprehensive strategic review of its international investment portfolio, Emirates Telecommunications Group Company PJSC ("e&") announced the termination of its Relationship Agreement...
Infiniti Indah Announces the Return of Pesta Kuantan 188 from 31 July to 2 August.
Bringing 14 Exciting Event Experiences for the People Expecting to draw more than 100,000 local, domestic and international visitors KUANTAN, Malaysia, July 9, 2026 /PRNewswire/ -- Infiniti Indah Sdn. Bhd. (Kuantan 188), a subsidiary of Trinidad...
InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation
NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical...